Novel serum tumor marker, RCAS1, in pancreatic diseases

doi:10.3748/wjg.v11.i33.5199

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1463)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

179

HTML

997

Figures (1-1)

165

Tables (1-4)

122

Sum=1463

Sep 7, 2005 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 7, 2005; 11(33): 5199-5202
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5199

Open in New Tab Full Size Figure Download Figure

Figure 1 Receiver operating characteristic curve indicating test performance indicating pancreatic carcinoma for the following threshold values, 5, 10, 15, 20, 25, and 30 U/mL. ●-●, performance in distinguishing benign from malignant pancreatic disease.

Citation: Yamaguchi K, Enjoji M, Nakashima M, Nakamuta M, Watanabe T, Tanaka M. Novel serum tumor marker, RCAS1, in pancreatic diseases. World J Gastroenterol 2005; 11(33): 5199-5202
URL: https://www.wjgnet.com/1007-9327/full/v11/i33/5199.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i33.5199